Interactive Transcript
0:02
Hello and welcome to Noon Conference hosted by M R I Online Noon
0:06
Conference connects the global radiology community through free live educational
0:11
webinars that are accessible for all and is an opportunity to learn alongside
0:15
top radiologists from around the world.
0:18
We encourage you to ask questions and share ideas to help the community learn
0:22
and grow.
0:23
You can access the recording of today's conference and previous noom conferences
0:27
by creating a free M r I online account.
0:29
You can also sign up for a free trial of our premium membership to get access to
0:33
hundreds of case-based micro-learning courses across all key radiology
0:37
subspecialties. Today we are honored to welcome Dr.
0:41
Deborah Baumgarten for a case-based review of renal pathology. Dr.
0:45
Baumgarten completed medical school and all of her radiology training at Emory
0:49
University.
0:51
She was on staff at Emory for over 25 years before moving to Mayo Clinic in
0:54
Jacksonville,
0:55
Florida in 2020 where she specializes in abdominal imaging with a special
0:59
interest in ultrasound and GU imaging. At the end of the lecture,
1:03
please join Dr.
1:04
Baumgarten in a q and a session where she will address questions you may have on
1:08
today's topic.
1:09
Please remember to use the q and a feature to submit your questions so we can
1:12
get to as many before our time is up. With that,
1:15
we're ready to begin today's lecture. Dr. Baumgarten, please take it from here.
1:20
I am thrilled to be here to do a case-based review of renal pathology. Um,
1:24
I encourage you to use the q and a um, also,
1:27
but also I'm gonna have you use the chat feature as well 'cause I'm gonna ask
1:31
you guys some questions and see how you can answer some of these as well.
1:35
So my goals for today
1:39
are that we're gonna get you thinking beyond clear cell renal cell carcinoma.
1:42
When you see a mass, don't automatically knee jerk to renal cell carcinoma,
1:46
especially clear cell variety and also give you some tips on expanding to
1:51
a reasonable differential. So here's our first case.
1:57
Um, it's a 66 year old male who has an elevated prostate specific
2:01
antigen.
2:02
So he was being seen for a prostate M R i but this is the T two
2:07
coronal sort of scout imaging as you will that we would do ahead of time.
2:11
And can anybody tell me which kidney I'm worried about the right or the left.
2:16
If you wanna just type right R or L in your, your chat box. I'll see if,
2:20
if we have a vote here. Okay, great.
2:24
Some people are putting left. Excellent. So as you can see here,
2:27
there's a lesion that's sticking off the bottom of the left kidney,
2:31
clearly not one on the right. So it's incidental.
2:35
The patient then underwent a renal mass protocol workup.
2:41
So we have our non-contrast image,
2:44
we have our arterial phase,
2:47
we have our nephro graphic phase and we have our delayed phase.
2:51
So here's a quick question for you all. Looking at that mass,
2:55
do you think it's true or false?
2:58
Can the enhancement pattern of this lesion help us differentiate
3:03
clear cell renal cell from other tumors such as oncocytoma or other
3:08
forms of renal cell carcinoma such as papillary or chromophobe?
3:12
Do you think that's a true or false statement?
3:14
Go ahead and put T or F or true or false in the chat box.
3:19
Okay, we're all over the place. Good. So some people are saying true,
3:24
some people are saying false and the way I'll answer it is that it's true to a
3:28
point and I'm gonna show you a paper that'll help us sort that out.
3:34
So this is a, a graph,
3:38
a depiction of the enhancement patterns on unenhanced cortico magary neph
3:42
infographic and excretory phases of 298 masses in
3:47
274 patients. And this was published in radiology in 2013.
3:52
And what they found was that clear cell carcinoma,
3:55
which is this top blue line,
3:58
enhanced more than the other subtypes and more than oncocytoma
4:04
and it was accurate.
4:05
This form of enhancement was accurate to differentiate renal cell clear cell
4:10
renal cell from the other masses between 77 and 85% depending upon
4:15
what you were comparing it to.
4:18
Unfortunately the next most avidly enhancing mass is benign and
4:22
oncocytoma, which has a very similar pattern to renal cell carcinoma.
4:27
Although the peak enhancement is a little bit less,
4:29
but you can imagine it's very easy to confuse these two.
4:34
You'll note that chromophobe and papillary renal cell carcinomas enhanced
4:38
in a later fashion generally and again not as much as clear cell
4:44
and oncocytoma.
4:48
So here's an arterial phase and a venous phase on a trauma patient.
4:52
And this was a 19 year old kind of unusual to find a renal mass in
4:57
a 19 year old. But there is a large left renal mass that we can discern here
5:03
already based on the age.
5:04
I mean we're really not thinking about renal cell or at least not clear cell
5:08
renal cell 'cause those are way more common in middle aged men. And again,
5:11
this is a 19 year old incidental with a trauma scan
5:16
but the enhancement pattern is pretty similar to clear cell renal cell
5:20
carcinoma. So given the age and the enhancement pattern,
5:25
this turned out to be an oncocytoma. So again,
5:28
it can be confused for a renal cell but we've gotta use other information as
5:32
well. So
5:36
here's another example of an oncocytoma.
5:38
This was a 75 year old female and she had an incidental mass on a PET scan
5:43
that was performed for other reasons.
5:46
So it follows the expected enhancement pattern of
5:52
a oncocytoma. We have a peak,
5:54
it's 102 in the cortical medullary phase and then it starts fading
5:59
73 and 66.
6:03
But we can't be certain this isn't a renal cell carcinoma.
6:07
So she underwent a biopsy and this was done in 2018 to confirm and it came
6:12
back as an oncocytoma.
6:14
She presented a couple of years later and the mass had grown.
6:17
You can see now it's actually a little bit more exophytic than it had been
6:20
before. Here it's not really deforming, the contour of the kidney,
6:24
it's sticking out a little bit. And again,
6:27
she underwent another biopsy this time though it was done by ultrasound and it
6:31
did again confirm that it was a benign oncocytoma.
6:35
So even benign lesions can grow but she just ended up under,
6:39
ended up going through two biopsies to prove that it was not a renal cell
6:43
carcinoma. Here's another lesion.
6:48
This is a 62 year old man with a very small incidental mass that's in the
6:53
left kidney. You can see it there. There's very little enhancement here.
6:58
So pre contrast it was 30 so it's a little bit hyperdense compared to
7:03
a simple cyst or something. Cortico medullary,
7:06
it was only 43 nephro graphic,
7:09
it was 48 and on the delayed it was 51.
7:12
So it went up just over 20 hounds field units over the course of time.
7:17
So what uh, enhancement pattern do you think this is more typical of?
7:21
What sort of tumor would we be thinking about with this kind of very low and
7:26
then delayed enhancement? Papillary good.
7:29
A couple of people said papillary and indeed this is papillary.
7:33
It's not chromophobe
7:40
but good for, for good measure.
7:42
I thought I would actually show you a chromophobe also.
7:45
So here we have the density at pre contrast is 36.
7:50
Once we give contrast material 118 and this one was
7:55
58 on the more delayed phase.
7:57
So this has a lower peak enhancement but still in this case did enhance and I
8:02
think we'd have a hard time saying this wasn't a clear cell but it did turn out
8:06
to be a chromophobe renal cell carcinoma on resection. All right,
8:11
our next index case is a 68 year old male and he has
8:16
metastatic melanoma as well as a diagnosis of low grade lymphoma.
8:21
And this is a scan of his from May of 2019. Um,
8:26
he does have some sort of high density material in the paracolic gutter here,
8:30
but what I'm more concerned about is this lesion that's sitting adjacent to or
8:35
maybe arising from the kidney. Hard to tell on a single image.
8:40
So I wanna know what you think the best diagnosis is of this and I'm gonna give
8:44
you a multiple choice here. So maybe this is lymphoma,
8:48
we we can have perineal lymphoma, could this be his melanoma,
8:52
could it be a lymphoma or is this some sort of an abscess sort of
8:57
thing?
8:59
So there's really no difference in density as we can really discern on the
9:04
original phase. That's portal phase and on the more delayed phase.
9:08
But before we actually answer the question,
9:10
I've got a couple people saying lymphoma,
9:11
let's just take a look back and forth in time.
9:15
So this is what he looked like in May, 2019.
9:17
This is the index that I showed you.
9:20
There is actually an additional lesion that we can see here,
9:25
but so this is now March of 2019 and we have this lesion here that's growing
9:29
along the um, wall of the uh,
9:32
sort of the lateral abdomen here and maybe there was something we could have
9:37
picked up in that region back in March but it wasn't called at that point and
9:42
now it's gotten a lot bigger.
9:45
You can tell though that the lesion near the kidney looks fairly similar.
9:49
Move forward a couple of months and this lesion is getting much larger.
9:53
So we can tell that this is a very aggressive process,
9:56
whatever it is that's going on. But again,
9:58
the lesion that's near the kidney is relatively stable.
10:03
So this is our index case here again.
10:08
So what do you all think? So now we're saying well lymphoma,
10:10
I've got one vote for lymph angio.
10:14
So this is our pararenal lesion.
10:17
It's relatively low attenuation kind of water.
10:20
This is another patient with another diagnosis.
10:22
This is a diagnosis of lymphoma or perren lymphoma.
10:26
You can see it's more soft tissue attenuation.
10:29
So our answer is that some of you have rightfully said a lymph angio.
10:35
So these are relatively rare benign mesenchymal neoplasms.
10:39
They are neoplastic but not malignant.
10:43
They can look like this be sort of multilocular, they can be unilocular,
10:47
they may be focal, they may be more diffuse, they can be bilateral,
10:51
they can kind of be almost anything. Um,
10:54
I'm excluding an abscess in this case because there's really no enhancement of
10:58
the wall of this thing.
10:59
And there was also no associated inflammation here and there was no uh,
11:04
change in this over time and you'd expect an abscess would've done that.
11:09
Now this is another patient with a much larger perren lymph
11:14
angio you can see here.
11:18
But it looks relatively ocular in these images and it looks relatively,
11:22
you know, very non-aggressive.
11:24
There's just really nothing much going on with it.
11:27
The patient came back less than two weeks later and it looks a little bit
11:30
different.
11:32
The patient also has sudden onset of pain on that side.
11:36
So what do you all think might be going on here?
11:42
Does anybody have a guess? Yeah, someone says infection rupture.
11:47
Okay,
11:48
good you all are thinking along the right terms 'cause we do see that there is
11:52
some uh, inflammatory change or fluid around the kidney too.
11:57
So now we have some enhancing septa.
11:59
We have a perceptible enhancing wall now and again there's some fluid and
12:03
inflammatory change if we look very carefully here next to the kidney versus
12:07
that area. Previously it also looks like it had gotten a little bit bigger.
12:12
So this is now an infected lymph angio.
12:15
So those of you who thought maybe it was infected were correct and this patient
12:18
had it drained and then sclerosis. All right,
12:22
we're gonna move on to the next case here,
12:25
which is a 76 year old male who has a diagnosis of myelo dysplasia.
12:31
So we have a portal venous scan here and we see there's sort of a mixed
12:35
density lesion in the central kidney. Is it in the sinus?
12:41
It's hard to tell.
12:42
It's hard to say whether it's in the collecting system at this point too 'cause
12:45
we don't really define what is the collecting system.
12:49
So what are we gonna do next?
12:53
Somebody says T C C, we wanna know if it's in the collecting system.
12:56
What's the best way for us to now move forward and decide A C T U?
13:01
Okay,
13:02
so if this were an incidental finding and we weren't doing a CT urogram and we
13:07
have technologists that are very uh, attuned to what things look like,
13:12
you may actually end up with a ex an excretory phase just by accident because
13:16
the,
13:17
the texts know that if they see something funny they should just go ahead and
13:21
re-scan it. So here's our case
13:26
at this point. Again, our best diagnosis this could, this could be a lymphoma,
13:31
this could be a urothelial carcinoma. We haven't excluded that yet.
13:36
Extramedullary,
13:37
hematopoiesis an odd thing or could this be an
13:41
angiomyolipoma? So let's rule out one of these right away.
13:46
I'm gonna take all of your advice and I'm gonna do that delayed set.
13:49
So here's my delayed image and we can see clearly that the collecting system is
13:53
running right next to it, but this is not actually within the collecting system.
13:57
This is a slightly different level than this one was the original.
14:00
So we're going to exclude urothelial carcinoma right away. But again,
14:05
before we give the correct answer I wanna go back and forth in time because I
14:09
can. So here's our index time, November of 2016.
14:13
Again that lesion here that looks soft tissue,
14:16
maybe a little lower density tissue here again in the central sinus.
14:21
If we go way back to August, 2005,
14:24
this patient's beginning his care at the hospital a long time.
14:29
We can see that the central sinus really looked normal. Okay?
14:33
And if we go ahead a couple of years we see that the lesion has gotten bigger
14:38
but a little bit less dense. It looks more fatty.
14:42
So it is actually wasn't there a long time ago and then has changed over time
14:47
and actually becomes less aggressive looking.
14:53
So now we've already gotten rid of urothelial carcinoma as a an answer.
14:58
So I see a couple of votes for extramedullary hematopoiesis and I think given
15:03
the history of myelodysplasia,
15:05
I think I might've given it away before we actually went through any of these
15:08
iterations. But here we go. That's what this turned out to be.
15:14
This underlying um,
15:17
this diagnosis is also associated with um,
15:20
other anemias like hemolytic anemia or other hemoglobin neuropathies.
15:25
You can see um,
15:26
extramedullary hematopoiesis in patients that have leukemia lymphoma.
15:31
Um, sometimes even if you have metastatic disease to the skeletal system that
15:36
replaces a lot of the marrow,
15:38
you can also have areas of extramedullary hematopoiesis.
15:42
So it isn't specific to myelodysplasia but this is one pattern of it where you
15:47
get kind of a mixed density soft tissue and,
15:50
and almost a little bit fatty mass.
15:55
So this is an example of a second pattern in another patient who had
15:59
myelodysplasia. She presented um, when she was 85 at um,
16:04
in 2014 and there is this soft tissue that's kind
16:09
of infiltrating around both kidneys and this really
16:14
mimics lymphoma.
16:15
So here are two different patients with lymphoma that looks a lot like our case
16:20
of extramedullary hematopoiesis.
16:23
So lymphoma is also really good to leave in the differential for something that
16:27
looked like our index case or in this case one with a little bit more
16:32
perinephric and tissue and tissue involving the renal sinus.
16:37
We also included angiomyolipoma on the differential just because
16:42
it's again a mixed soft tissue and fatty mass. Um,
16:47
you can usually find the site of origin from the kidney especially when they're
16:50
exophytic 'cause you look for that, you know,
16:52
infamous beak sign and you can tell that this is arising from the kidney.
16:58
You wouldn't have a beak sign with extramedullary hematopoiesis that presented
17:03
with a soft tissue and fatty mass.
17:04
So that might be another differentiator as well.
17:08
We can also have very large angiomyolipoma and I don't think anybody's gonna
17:12
mistake this for anything but an angiomyolipoma.
17:15
It also has a really nice beak sign.
17:20
Alright, let's move on to our next case. She's 72,
17:24
she has anorexia, she has some right upper quadrant pain,
17:27
she's been losing some weight
17:31
and we see a small sort of ill-defined lower pole mass
17:36
or maybe a mass like area in the right kidney.
17:39
And at this point in time this was the only abnormality in the kidney.
17:43
So what do you wanna put in the differential?
17:46
Anybody think of anything that might wanna put? Okay,
17:49
I am getting focal infection or focal pilo got two votes for that renal cell
17:54
carcinoma. Also a good thought.
17:58
So some of the things I'm gonna put in the differential,
18:01
I'm gonna put lymphoma in the differential. I'm gonna put a renal cell,
18:07
I'm gonna put urothelial, I'm gonna put focal pile and nephritis.
18:11
But is this really the order in which I would, you know,
18:14
list these as my differential when I do my report and say hey,
18:19
this is what things could be. I don't think that's,
18:22
this is really the differential. I would put this way.
18:25
The order of likelihood I think I'm gonna put focal pile and nephritis first.
18:29
It is rather ill-defined the patient has been having some
18:34
kind of vague symptoms.
18:35
But again these are symptoms that could also go along with a malignancy.
18:39
So I'm gonna put malignancy second a renal cell before I put urothelial cell
18:44
and I think I'm gonna put lymphoma much lower down. It's um,
18:49
can present as a focal mass but generally has more than one mass and they're
18:53
usually a little more homogeneous than this.
18:55
And I'm gonna give you examples of all of these anyway.
18:57
So this is the order of likelihood I'm gonna put these in.
19:00
Someone else mentioned infarction,
19:02
which I also like in terms of its shape,
19:06
but I would expect to see a little bit less enhancement here unless this is
19:10
actually not enhancement but some hemorrhagic component in which case maybe
19:15
infarct would be a good choice as well.
19:19
So the patient actually underwent a renal mass protocol CT two days later.
19:23
She had the full gamut, she had her non-contrast, her arterial,
19:27
her nephro graphic and her delayed. And this is that same area,
19:30
which as we'd expect didn't change very much over
19:35
a couple of days. However,
19:38
we were able at this point to see a couple of other areas of abnormality in that
19:42
right kidney here. A little bit of uh,
19:45
another little focal area anteriorly and then a little more um,
19:50
rounded area. And this is not the same clearly as the other area.
19:53
So now it's a multifocal process and in the meantime
19:58
she has undergone a urinalysis and
20:03
a urine culture. And what do you think
20:08
it grew? What's the most likely candidate?
20:13
E coli. Exactly. Exactly. And that's what she grew.
20:19
I'm gonna pause here for a second. There's a couple of questions in the, uh,
20:22
question and answer box. So someone asked, I've shown you that we,
20:25
we do a four-phase renal mass protocol here. Is that the recommended protocol?
20:30
It really depends on the indication for what you're doing in the kidney.
20:34
If you are working up a mass at the very least you need a
20:39
non-contrast.
20:40
You need either an arterial or a nephro graphic or even a portal venous phase.
20:46
And then I think a delayed phase is helpful.
20:48
So I think at least three phases are helpful.
20:51
The reason to add the arterial phase would be if you're doing presurgical
20:55
planning and you wanna see the relationship of the renal artery,
20:58
how many renal arteries, that sort of thing. Um, it's helpful for that.
21:03
Um, in where I was before Mayo Clinic at Emory,
21:07
we only did routinely three phases.
21:09
We'd add the fourth arterial phase again depending upon the indication,
21:14
mostly for preoperative planning. Three phases are adequate I think.
21:19
Um, at Mayo Clinic they just prefer to do four phases.
21:21
So I'm kind of going along with the, with the group, um,
21:26
pseudo tumors versus recurrence of renal cell.
21:29
A little out of our realm for this particular case.
21:32
But I'll see if I can get back to that a little bit later. So just remind me.
21:38
Okay, here's that same patient with the multiple areas of abnormality.
21:42
We've got posterior here, a little bit anterior here. So, oh,
21:47
I'm sorry, I got off a little bit. This is another patient, sorry,
21:51
this patient was being screened for cirrhosis and she has again this sort of
21:55
wedge-shaped area here, but also a little bit of abnormality anteriorly.
21:59
And she was as far as we knew, asymptomatic. However,
22:03
when we brought up the possibility that she might have focal pile and nephritis,
22:08
the patient said, well maybe she'd had some fevers at home.
22:13
Um, so they went ahead and did uh, urine cultures and she also grew e coli.
22:17
So this is just another example here of more focal pile and nephritis and again,
22:22
maybe some other subtle abnormality on a more delayed phase here.
22:28
So somebody's asking me about what about IgG four diagnosis?
22:31
That is another possibility. When you see focal renal masses like this,
22:36
I would hope you would also see something wrong in the uh,
22:41
pancreas or perinephric per pancreatic space. Um, you're also not gonna grow,
22:45
clearly not gonna grow e coli on a culture or have an abnormal urinalysis.
22:50
So you have to perhaps think about that in your differential.
22:54
It's not something I trained thinking about.
22:56
It's actually a diagnosis that was described well after I finished my training.
23:02
Um, that I I guess is not top of my brain all the time,
23:05
but is a very good suggestion 'cause that can also present with sort of rounded
23:09
masses.
23:09
The ones I've seen when I've seen it involve the kidney have had more than one
23:13
lesion. Um, but I'm sure there are examples where it's only a single lesion.
23:19
So again, yeah, something else to think about.
23:22
And here's just a more typical case of pyelonephritis to me where we have
23:28
multiple wedge-shaped areas that are involving also the cortex
23:32
of the kidney, not just the medullary regions.
23:35
So you really get blurring of that cortex where here's a little bit more normal
23:39
cortex and then some more cortex that's not quite as normal.
23:45
The other differentiator here is that sometimes with infarction or often with
23:49
infarction you can get preservation of the renal capsular flow.
23:54
So you get that little rim of enhancement around a wedge-shaped area.
23:58
So that can help you differentiate in some cases between infection and
24:02
infarction.
24:05
So this is an example of urothelial carcinoma,
24:08
again presenting on the axial image as a solitary sort of rounded
24:13
area. But when we look at this coronal, you can see that it,
24:17
although it's preserving the renal shape, it's very infiltrative.
24:21
We also have some preservation of that capsule or a little bit of that cortical
24:25
flow here, which again is a bit of a differentiator from infection.
24:34
And again, for completeness sake,
24:35
this is an example of lymphoma where we have multiple very homogeneous
24:40
soft tissue masses involving both kidneys in this case.
24:43
A little asymmetrically on the right greater than the left. So again,
24:48
more homogeneous and and multiple is another pattern of lymphoma.
24:56
Okay, moving along to our case five,
25:00
we have another female and she was being scanned for abdominal discomfort. So
25:07
I'll just let you look at this for a second and then I'll point out that there's
25:11
this rather large mass like area or mass in the
25:16
mid kidney here and you can see it here on the washout as well.
25:24
And if we look, it's following the blood pool here.
25:27
So it looks very similar to the aortic enhancement.
25:31
Does anybody have any guesses?
25:33
So somebody says a column of burin 'cause it does kinda look like the kidney to
25:37
some extent. A hemorrhagic cyst lymphoma,
25:40
T C C A hemangioma aneurysm, I like aneurysm.
25:45
Kind of like it. All right,
25:47
the next phase is going to sin s**t.
25:50
So that's why I kind of skipped this lesion to start this uh,
25:53
image to start with. So here's the next image for you all.
26:00
Now what do you all think this is?
26:04
So this was the index area, but now we have all this other
26:10
serpiginous vascularity here. So yes,
26:13
arteriovenous malformation is what this is.
26:19
So it's just something else to think about.
26:22
And when you have a very homogeneously enhancing lesion, um,
26:26
whether or not you initially see the other vessels associated with it,
26:30
if it follows the blood pool,
26:32
you have to at least think about a very vascular lesion.
26:37
So now I'm gonna show you this as a, as a companion case.
26:40
And this is a 75 year old who had a diagnosis of a pancreatic mass,
26:45
which you can see here. Now why am I showing you this as a companion case?
26:49
Just hold your horses, we'll get there.
26:54
Has this lesion also had innumerable pulmonary nodules as we can see here,
26:59
just lots and lots of them. So we're already thinking, okay,
27:01
this is metastatic pancreatic cancer potentially and that's what it was presumed
27:06
to be a metastatic neuroendocrine pancreatic cancer.
27:11
But here's the rest of this case.
27:16
So we look at his right kidney and we see a lesion here that is
27:21
again following the blood pool. It looks a lot like the one I just showed you.
27:25
That's sort of a big serpiginous looking thing here.
27:30
But it also has a bit of a mixed sort of cystic solid component posteriorly here
27:35
that's a little bit different. That really didn't look like a vessel.
27:38
So it looked a little bit more complex than perhaps that very clean arterial
27:42
venous malformation.
27:44
So someone's thinking metastatic pancreatic from clear cell renal cell. Okay,
27:49
renal cell with an AV f maybe some thrombus in here. These are all really good,
27:55
really, really good thoughts.
27:56
So what happened next was the patient actually underwent a lung biopsy 'cause
28:00
they figured, well this'll prove where it's coming from.
28:05
And this turned out to be metastatic renal cell carcinoma.
28:10
So this, as several people suggested,
28:14
was metastatic to the lung,
28:16
was metastatic to the pancreas renal cell likes to go to the pancreas and other
28:19
retroperitoneal structures. So you know, if it looks like, uh, a horse,
28:25
it's a horse, if it looks like a zebra sometimes it's still a horse.
28:28
So common things being more common.
28:30
This was a renal cell that went to the pancreas and the lung and
28:35
they can have very large vascular channels within them or even have, you know,
28:40
a, a arterial venous connection.
28:44
So this is another example of something that looks very vascular.
28:48
So in this case though,
28:50
the lesion is very vascular but not enhancing as much as the aorta
28:55
on this very arterial phase. So again,
28:58
a little bit less than the aorta and iliac vessels.
29:00
And then on the more delayed phase,
29:03
it's actually retaining contrast a little bit more than the aorta.
29:07
So it's not washing out as fast.
29:09
Does anybody have a thought about what this vascular lesion might be?
29:15
So it's a little bit slower to enhance but then it hangs onto the contrast
29:20
material. Okay,
29:24
they're thinking you're thinking of angio. Okay,
29:28
I'm not sure I've ever actually diagnosed a hemangioma within the kidney.
29:32
Oh here we go. Someone just mentioned pseudo aneurysm.
29:36
Excellent and an A M L 'cause those can have aneurysms in them as well.
29:41
This did actually turn out to be a pseudo aneurysm.
29:43
The part of the history that I withheld is that the patient had undergone a
29:47
partial nephrectomy. So this was a post-procedure pseudo aneurysm.
29:52
So the contrast may wash in faster but it may not, and then it, it,
29:56
it held onto it in this case. So this patient then had to go on to um,
30:00
angiography and embolization so that hopefully it wouldn't, you know,
30:04
before it would rupture and cause a catastrophe.
30:08
Here's another example of a post-procedure pseudo aneurysm in this case on an
30:11
ultrasound,
30:12
this patient was sent in thinking that he had a recurrent renal cell,
30:17
but this was way too close to his original surgery.
30:20
It was only a matter of a couple months.
30:22
And this lesion looked kind of large but you'll notice it has kind of a thick
30:26
wall here,
30:27
a cystic space centrally which starts to fill in with contrast or,
30:31
or at least color flow on the color flow imaging.
30:33
So this was an additional pseudo aneurysm following a partial nephrectomy.
30:38
This was not a recurrence of renal cell.
30:43
Okay, we're moving right along here. We have case six,
30:46
which is a 74 year old female who had another incidental finding on a ct.
30:52
So I've shown you both kidneys.
30:53
I think you can see that there's a lesion here in the right kidney.
31:00
And if we look at the density measurements on it, it starts out at 37.
31:04
So it's a little bit denser than the adjacent kidney.
31:08
It goes to 65 on the um,
31:11
portal venous phase and on a more delayed or nephro graphic phase, it's 71.
31:19
So this enhancement pattern,
31:23
it's similar to a papillary renal cell carcinoma but I showed you one of those
31:27
already. So somebody has said A M L, what else is that?
31:32
Chromophobe R cc. Okay, I like that answer too. Going back to our first slides,
31:37
if this were an A M L,
31:39
does anybody know the buzzwords that go along with this particular type of A M L
31:46
lipid Poor? Yep. Or fat poor A M L.
31:50
And that's what this was. This was a lipid poor A M L.
31:53
The problem with these lesions though is that you can't always differentiate
31:57
them on CT based on this.
31:58
So some people have looked at multiparametric M R I,
32:02
there are some features that might help you determine that it's a lipid poor A M
32:06
L, but if that's not helpful,
32:10
things that are are is it stable over time?
32:13
So this patient two years later it looks exactly the same and four years later
32:17
looked exactly the same.
32:19
So we were very confident without a biopsy that this is indeed a lipid poor A M
32:23
L. But some patients do go on to biopsy of these lesions and in certain cases it
32:28
may be appropriate to biopsy them to prove that it's a lipid poor A M L.
32:34
Okay, this is a,
32:37
I'm gonna contrast this with this particular patient who's a 39 year old
32:42
and this was a chest CT as you can tell.
32:45
And at the very bottom and not even completely included,
32:49
was this lesion sticking off of the right kidney.
32:53
It's slightly denser than the renal parenchyma.
32:55
So it may be solid or it may be hemorrhagic at this point we really have no
32:59
idea. So the patient underwent an ultrasound
33:03
and the lesion has some echogenic areas. So our first thought might be,
33:08
well could this be an angiomyolipoma or is it just a hemorrhagic
33:13
cyst? So what would be the next thing you do with an ultrasound?
33:17
You've got the patient on the table, what are you gonna do next
33:22
Doppler? Absolutely.
33:24
So we turn on the Doppler and clearly there's flow at least in parts of this
33:28
lesion. So it's solid,
33:32
it's not a complex cyst.
33:34
So this patient actually underwent an M R I for further further evaluation and
33:38
it's pretty heterogeneous on this T two weighted image.
33:42
There was no discernible fat in it.
33:46
There's nothing at least internally that's causing any India ink artifact
33:49
inside. It did have a little bit of enhancement,
33:53
which maybe we can see a little bit better on subtracted imaging.
33:56
And this lesion turned out to be a papillary renal cell carcinoma.
34:01
So although we thought potentially could have been a fat poor A M L,
34:05
this ultimately got resected and was a papillary renal cell.
34:09
So there are all kinds of things that can be incidental.
34:15
All right, moving along to our case number seven,
34:17
we have a 60 year old male and he was undergoing a routine renal ultrasound
34:21
because he had an elevated creatinine
34:25
and now this lesion that I'm showing you is a little bit different than the
34:28
other lesions 'cause it seems to be in the collecting system as we can see
34:33
here,
34:33
there's definitely hydro and I'm gonna show you two cine clipse and
34:38
the arrow is just keeping your attention on that area there,
34:41
showing you where that lesion is.
34:42
You can see the hydro and then this is a transverse kind of going back and forth
34:47
and it's hard to keep the lesion in in the plane but it's
34:52
right there.
34:58
So what would be the next step do you think in this patient's workup?
35:07
C T U. Exactly. So this is the patient CT urogram.
35:11
I'm only showing you the non-contrast and the uh,
35:15
initial nephro graphic phase because this kidney did not excrete even after
35:20
45 minutes so it didn't really help.
35:23
But what we can see is that initial lesion that was in the pole of the kidney.
35:29
But we can also see that there is a soft tissue lesion that's filling the
35:32
ureter. That's probably the source of the bad he um, hydro nephrosis,
35:37
you can see a little bit of thickening here as well.
35:39
So this was multifocal urothelial carcinoma as several of you had suggested.
35:44
It might be.
35:48
I'm getting kind of close to time but I wanna see if I can get through a couple
35:51
of more cases here 'cause this next one is a point that I would really like to
35:54
drive home. So this is a 77 year old female,
35:58
again incidental on CT as so many of our renal lesions are.
36:02
She actually has two lesions,
36:03
one that looks relatively water attenuation and another one which is clearly not
36:08
water attenuation. So what do you wanna do next? Nothing.
36:12
You know she's 77, they look small, they don't look very aggressive.
36:17
Do you wanna do an M R I next?
36:19
Do you wanna do a contrast enhanced ultrasound or something else?
36:24
Ultrasound's a good thought.
36:26
It's probably the least is clearly the least invasive.
36:29
So C E U S might be but I'm gonna tell you there's something else we can do.
36:32
And again this harks back to whether you have technologists that know they
36:36
should go back through things that look funny for you.
36:42
So first thing I'm gonna do is just give you a density measurement and it is
36:45
indeed 48 and this was indeed the other one was indeed fluid attenuation.
36:50
So I'm gonna tell you we're gonna do something else. So here we are at 48
36:55
but our text went through and did a delayed image and it's 47.
37:02
So this did not wash out.
37:06
If it didn't wash out it means it didn't wash in.
37:09
So there's no enhancement in this lesion and this is a pretty good rule of
37:13
thumb. If you wait a couple of minutes and nothing changes,
37:16
you can be pretty sure that it's not a very vascular lesion or not a vascular
37:20
lesion at all. So this is a complex cyst,
37:23
it's either hemorrhagic or proteinaceous.
37:25
And at this point if you were still not sure, hedging your betts a little bit,
37:30
a regular ultrasound would be plenty to show that this was just a hemorrhagic
37:35
cyst or a proteinaceous cyst.
37:39
Let me compare that to this particular case.
37:42
So here we have a lesion that's exophytic, that's 53 hounds field units,
37:47
but again we're deli,
37:48
we're aided by delayed imaging and it's 48 hounds field units.
37:53
Five hounds field unit change is not enough to say that something washed in.
37:58
So in this case,
37:59
again it just shows you that this is a complex cyst but just in case we had
38:03
doubts, this patient had come back almost a year later,
38:07
it was exactly the same so we were correct.
38:09
This is just a hemorrhagic or a proteinaceous cyst.
38:13
On the other hand we see this leash in here
38:18
and it's 112 hounds field units
38:22
on our delayed set it's 82 hounds field units.
38:27
So on delayed imaging this washed out 30 hounds field units.
38:31
So we know it washed in. So we know that this is an enhancing lesion.
38:35
So even without non-contrast images we can be confident that this is a
38:40
vascular lesion and in this case it turned out to be a papillary renal cell.
38:45
Again, not enhancing as much as a clear cell.
38:50
And again, just to prove this point,
38:52
'cause I think it's really important to rely on all of the imaging that we have
38:56
on a patient. We see this little lesion here and granted,
39:00
nobody's gonna think this is not suspicious.
39:03
It's got what it looked like multiple little septations that are probably
39:07
enhancing and it has a density of 103 and here's the
39:11
delayed set.
39:13
It's much more homogeneous at this point but it's 74 hounds field unit
39:17
so we know it washed out and this turned out to be a very small incidental clear
39:22
cell renal cell carcinoma.
39:26
All right and then just as a bonus case, this is I promise the last one,
39:30
what do you all think this is?
39:33
Anybody have any ideas? Okay, X P N.
39:40
Good thought.
39:42
I'm gonna show you this is the same diagnosis in another patient.
39:46
Does this help? Yep. Antho granuloma is excellent.
39:51
So I'm going back to our original case here. In this case though,
39:56
usually they're associated with or often associated with stones.
39:59
In this case it's sort of more segmental because a stone is in the upper pole,
40:02
not in the renal pelvis. In this case this is focal or segmental X G P.
40:08
And in this case it also has involvement of the extra renal tissues which it can
40:12
do, which gives it a more aggressive look than just a plan X G P.
40:18
So this is not malignancy but can be locally aggressive. Alright,
40:23
so I just wanted to show you that every mass and I put some of that in
40:27
quotations 'cause not every mass is even a mass.
40:29
Sometimes they're parts of infection or something else,
40:33
but they're not every all going to be clear cell renal cell carcinoma.
40:37
The characteristics of the abnormality can really help you expand your
40:41
differential including the enhancement pattern which is helpful but not a be all
40:45
end all. Also the location of the lesion and whether it's single or multiple,
40:50
don't forget about delayed images or even old images or images of another
40:55
body part that might include the area of interest. For example,
40:59
if the patient underwent a lumbar spine M R I,
41:02
you might have seen that something was there two years ago and it hasn't really
41:05
changed even though it might look a little funny on the,
41:08
the images you're seeing today, it might've been there two years ago.
41:11
And you know,
41:11
who knows if the person reading the lumbar spine m r I noticed it 'cause it's
41:15
not really in their, in their area of expertise.
41:19
Patient features also help you wanna know how old the patient is,
41:22
although unfortunately I'm seeing younger and younger patients with worse and
41:25
worse disease. So not every young person has a benign diagnosis,
41:30
but it does help. And then the symptoms can also help.
41:33
Does the patient have a fever, does the patient have an elevated white count?
41:36
What does their urine look like?
41:38
Can be very helpful And those are things that are not invasive and things you
41:42
can find out that might help you go toward one kind of a lesion or another.
41:46
So at this point I'm gonna see if I can answer some of these questions.
41:49
Do I believe in twinkling to assess calculus burden in urinary tract and to
41:53
differentiate calculus from milk of calcium?
41:56
Twinkling is an interesting phenomenon.
42:00
I think I see sometimes I see twinkling in the kidneys that I have no correlate
42:04
on a CT to show that it's a calcified or stone. I still,
42:09
we still use it but I,
42:12
I kind of put use it with an asterisk next to it.
42:15
But I also think that sometimes you can see things on ultrasound earlier
42:20
even than on CT and you might pick up a very tiny stone that you're really not
42:23
seeing on a ct. So I, I do, we do use it. Um,
42:29
and I certainly anything that is echogenic that I see in the kidney,
42:32
if I don't see shadowing the texts always turn on twinkling just to see if it
42:36
does twinkle and in which case I'd be a little bit more confident about a stone.
42:40
Gotta be careful about vascular calcifications that are in the hilum of the
42:43
kidney. Those can also cause an issue as well. Can I say again,
42:48
which kind of diseases the renal capsule vascularization enhancement are
42:52
preserved and which is not?
42:53
I mentioned that pyelonephritis to me in my experience tends to go the full
42:58
thickness of the kidney and also kind of obscure whatever capsular enhancement.
43:03
So pyelonephritis again can be all the way through and on a
43:08
cortico medullary phase of a, of a study, if that's all you have,
43:13
sometimes just the lack of that cortical enhancement may be your only clut pilon
43:17
nephritis.
43:18
So in those areas the cortex and the medulla are enhancing almost identically
43:23
and you see sort of um,
43:24
areas that do have cortical enhancement and areas that don't.
43:28
And if you wait a little while you'll get a more classic neph infographic phase.
43:32
Transitional cell carcinoma can obviously infiltrate
43:37
all the way through the kidney but it may not and you might still see a little
43:41
bit of capsular enhancement or cortical enhancement next to it.
43:44
Infarcts generally you still have capsular enhancement.
43:48
Do I have any experience with thrombotic nutcracker syndrome?
43:53
Um, Nutcracker syndrome, yes.
43:55
I'm not sure what you mean by thrombotic nutcracker syndrome. Um,
44:02
the Nutcracker syndrome is when um,
44:05
you have the left renal vein sort of crushed between the S M A
44:09
and the aorta. Um,
44:11
usually we don't consider it significance unless they're all so collaterals in
44:16
the left retroperitoneum. Um, it has to be causing some sort of an,
44:21
uh, a disturbance of renal flow for there to be collaterals and if there's no
44:25
disturbance in renal flow,
44:26
you normally don't get those and then it may not be a significant finding and we
44:29
tend to try to diagnose those with um,
44:32
ultrasound looking for elevated venous velocities and a change
44:37
in size of the renal vein.
44:39
Can heterogeneous enhancement in the cortico medullary phase be a normal
44:42
variant? Oh, I wanna ne I never wanna say never,
44:46
but I have to say that it's not,
44:48
I don't think it would be very frequent that you would get, um,
44:54
a, a heterogeneous cortico medullary phase as normal.
44:57
What is my thought about a combined neph graphic exploratory phase?
44:59
We do that in younger patients when we're doing hematuria workups and also, uh,
45:04
younger renal donors where we give a little bit of contrast initially
45:09
and then we combine it with a either arterial or neph infographic to get another
45:13
idea of what the kidneys look like.
45:14
So I think it's really good in younger patients when we're worried about
45:18
radiation dose. But in older patients where we don't have that same worry,
45:22
we prefer to separate them.
45:25
Am I using a bosniac classification on ultrasound? I am not.
45:29
I am describing things I'm giving differentials. Uh,
45:32
we use a lot of contrast material here in ultrasound that I didn't do in my old
45:36
place. Um, but I think it is more appropriate in CT and ultrasound.
45:40
I know people are trying to work on a bosniac for ultrasound.
45:43
I probably will become more apparent or more popular in time to come.
45:48
Which modalities preferred C two or M r I for a definite diagnosis?
45:52
I think it depends in part on patient's stability and what they can tolerate,
45:57
um, and what the radiologist who's reading it is comfortable with. Um,
46:00
in my practice I don't do a lot of M R I,
46:02
so although I can do M R I I I don't do a very much of it,
46:07
so I'm way more comfortable with ct. Um,
46:10
I think you can see more subtle enhancement on an M R I for certain things and I
46:14
think it's easier in some cases to get subtracted images on M R I,
46:17
although we can get them on ct. So I think, um,
46:22
it depends a lot. I mean if I,
46:23
I would rather have a good CT than a crappy M R I quite frankly,
46:27
or an M R I that has a lot of motion artifact.
46:30
So that answers another question too.
46:31
If somebody asked me if I preferred M R ct,
46:34
I actually prefer ct but like I said,
46:36
predominant presence of milk and calcium cyst is a rare pattern of A P K D pro
46:40
in children.
46:41
Do you feel it is common in adults and are we under diagnosing them on
46:44
ultrasound and doppler? Wow. Um, that is something I,
46:47
I can't say that I've given a whole lot of thought to milk of calcium cysts. Um,
46:52
'cause I don't do any pediatric imaging. Um,
46:55
I'll have to say I don't think we see it a lot in adults or if we do or we're
46:59
under diagnosing it because I don't think I've actually, um,
47:03
made a lot of diagnosis of milk of calcium cysts on ultrasound and doppler in A
47:08
P K D, how common is nutcracker cracker? In my experience,
47:12
not very. Um, I'm probably a little skewed because I'm at a, uh,
47:17
tertiary referral center and we get a lot of patients where we're screening for
47:20
Nutcracker because they have headaches and that seems to be an association that
47:25
the neurologists are now looking at. So I think I see workups for it,
47:29
it more like more often than it probably actually exists. Uh,
47:33
does a m l wash out? Is there any,
47:35
is there anything benign than wash out when we don't have non-contrast? Um,
47:43
AMLs should have wash out. Um,
47:46
I'm not sure if we do it early enough they may not wash out significantly.
47:51
Same with papillary.
47:52
It may be very difficult if it just doesn't quite reach that threshold of like
47:56
20 hounds field units. Um, so you've gotta use your best judgment,
48:01
your best guess. What are the other features of the mass AMLs also have, um,
48:06
are more prone to odd shapes like triangular and angular interfaces
48:11
with the kidney. So that might be helpful also. Um, and I, oh,
48:16
in terms of differentiating a renal sooner tumor versus recurrence of R C C?
48:20
Um, recurrent, if, if somebody thinks they had negative margins on a, on a uh,
48:25
partial nephrectomy, um,
48:29
I don't think you're gonna see a recurrence very quickly. You know,
48:32
not in the first few weeks, probably not in the first few months.
48:36
So I would think I know and, and also with ablations,
48:40
I know we tend to do like a three month follow up and then six months. Um,
48:45
I would say I would probably be not comfortable at three months to definitely
48:49
call a recurrence. I might be more comfortable at six months,
48:52
especially if something looked a little bit more lobular and chunky.
48:56
But um, in terms of differentiating it oof,
49:01
um,
49:03
I think some of that is comes with experience and some of it
49:08
is just seeing if the area you're talking about,
49:11
does it really follow the renal parenchyma on all of your phases or is there
49:15
something a little odd about it that gets your attention?
49:18
And don't be afraid to bring somebody back a little more quickly than you might
49:22
otherwise have if you're not comfortable with what something looks at looks
49:26
like. I think I actually got all of the questions and we are a little over time,
49:31
so thank you for hanging on and um, I will stop there.
49:35
Dr. Baumgarter,
49:36
thank you so much for sharing your lecture with us today and for everyone for
49:40
participating in this awesome case review. We really appreciate it.
49:43
You can access the recording of today's conference and all our previous noom
49:47
conferences by creating a free m r I online account.
49:50
Be sure to join us next week for a Noom conference with Dr.
49:53
Magic Khan for a lecture on Advanced Spine Imaging.
49:56
You can register for this free lecture@mrionline.com and follow us on social
50:00
medias for update on future noon conferences.
50:03
Thanks again and have a great day.